SCHEMBL11560902

SCHEMBL11560902

O=C(c1ccccc1)n1cc[nH]c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
PKM P14618 1/20 0.44
TYMP P19971 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
P2RX4 Q99571 3/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
HPGD P15428 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL913153 0.76 TYMP (0.51) TSHRRAB9AL3MBTL1KDM4ELMNA
SCHEMBL31009220 0.76
SCHEMBL14491 0.74 TYMP (0.49) TSHRRAB9APKMTYMPSIGMAR1
SCHEMBL11728159 0.74 MAPT (0.46) TSHRRAB9AKDM4EPKMP2RX4
SCHEMBL3015728 0.68 TYMP (0.54) TSHRRAB9ATYMPSIGMAR1GSK3A
SCHEMBL27636345 0.67 L3MBTL1 (0.47) TSHRRAB9AL3MBTL1KDM4ELMNA
SCHEMBL1418006 0.66 TK1 (0.49) TYMPHPGDDAO
SCHEMBL13341564 0.66 TSHR (0.46) TSHRRAB9AL3MBTL1KDM4ELMNA
SCHEMBL31621004 0.65 TYMP (0.60) TSHRRAB9ATYMPSIGMAR1GSK3A
SCHEMBL11792243 0.65 P2RX4 (0.59) TSHRRAB9AL3MBTL1TYMPSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102140095-A Green new process for preparing tizanidine hydrochloride CHANGZHOU YABANG PHARMACEUTICAL CO LTD 2011-08-03 CN disclosed
US-4168381-A Enhancement of enantioselectivity by iodide salts of Rh(I) complexes in the reduction of prochiral imidazolinones AMERICAN CYANAMID COMPANY (US) 1979-09-18 US disclosed